A Study of STSP-0902 Ophthalmic Solution in Healthy Subjects

Clinical trial NCT06597422 · COMPLETED

Trial details

NCT number: NCT06597422
Sponsor: Staidson (Beijing) Biopharmaceuticals Co., Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Neurotrophic Keratitis

Start date: 2024-10-20
Primary completion: 2025-01-23
Enrollment: 82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.